Coccidioidomycosis (Valley Fever) News 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Regional Analysis of Coccidioidomycosis Incidence - California, 2000-2018
This report describes regional analysis of coccidioidomycosis in California. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - December 3, 2020 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Valley Fever (Coccidioidomycosis) Source Type: news
Rift Valley Fever – Mauritania
The Ministry of Health (MoH) notified WHO that between 13 September and 1 October 2020, eight cases of Rift Valley Fever (RVF) including seven deaths were confirmed in animal breeders. Districts affected include Tidjikja and Moudj éria (Tagant region), Guerou (Assaba region) and Chinguetty (Adrar region). Laboratory confirmation of RVF infection was performed using a reverse transcription polymerase chain reaction (RT-PCR) at the National Institute for Public Health Research (INRSP) in Nouakchott. The age of infected patient s varied between 16 and 70 years old and included one woman and seven men. All seven deaths occurr...
Source: WHO Disease Outbreaks - November 13, 2020 Category: Infectious Diseases Tags: news Source Type: news
Sudan: Covid Testing Extended in Sudan
[Radio Dabanga] Khartoum -- The Ministry of Health of Khartoum state announced yesterday that COVID-19 tests for travellers can now be done at Jabra Hospital in Khartoum, and El Rakha Health Centre in Omdurman, in addition to other laboratories. Haemorrhagic and Rift Valley Fever are still spreading. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 29, 2020 Category: African Health Source Type: news
Valley Fever (Coccidioidomycosis) Awareness - California, 2016-2017
This report describes a survey of the general awareness of Valley fever in California. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - October 22, 2020 Category: American Health Tags: Fungal Diseases MMWR Morbidity & Mortality Weekly Report Valley Fever (Coccidioidomycosis) Source Type: news
SIMPONI ARIA ® (golimumab) Approved by the U.S. Food and Drug Administration for Active Polyarticular Juvenile Idiopathic Arthritis and Extension of Its Active Psoriatic Arthritis Indication in Patients 2 Years of Age and Older
HORSHAM, PA, September 30, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved SIMPONI ARIA® (golimumab) for patients 2 years of age and older for the treatment of active pJIA and has extended the PsA indication for this same patient population. “This latest FDA approval of SIMPONI ARIA for pediatric use in active pJIA and active PsA not only brings a new option to young patients living with these diseases but also adds to the growing body of evidence for this treatment,” said Mathai Mammen, M.D., Ph.D., Global Head, Jans...
Source: Johnson and Johnson - September 30, 2020 Category: Pharmaceuticals Source Type: news
Coccidioidomycosis (Valley Fever): Considerations for Development of Antifungal Drugs - 08/05/2020 - 08/05/2020
Developing Antifungal Drugs for the Treatment of Coccidiodomycosis (Valley Fever) Infection (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 31, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Coronavirus: world treating symptoms, not cause of pandemics, says UN
Ongoing destruction of nature will result in stream of animal diseases jumping to humans, says reportCoronavirus – latest updatesSee all our coronavirus coverageThe world is treating the health and economic symptoms of the coronavirus pandemic but not the environmental cause, according to the authors of aUN report. As a result, a steady stream of diseases can be expected to jump from animals to humans in coming years, they say.The number of such“zoonotic” epidemics is rising, from Ebola to Sars to West Nile virus and Rift Valley fever, with the root cause being the destruction of nature by humans and the growing dema...
Source: Guardian Unlimited Science - July 6, 2020 Category: Science Authors: Damian Carrington Environment editor Tags: Coronavirus outbreak Environment Wildlife Infectious diseases Farming Medical research Science World news United Nations Health Sars Meat industry Farm animals Source Type: news
Yellow fever – Gabon
On 15 April 2020, WHO received information regarding a confirmed case of yellow fever in Magandi village, Tchibanga city in Nyanga Province of southern Gabon, 590 km from the capital, Libreville. The case is an 83-year-old male with no known vaccination history for yellow fever. He had onset of symptoms on 30 January 2020 and presented to a health facility on 2 February 2020 with abdominal pain and jaundice. Between 2 February and 9 April, he consulted the Urban Health Centre in Tchibanga, the Christian Alliance Hospital in Bongolo and the University hospital in the capital Libreville where the case received anti-malarial...
Source: WHO Disease Outbreaks - June 17, 2020 Category: Infectious Diseases Tags: news Source Type: news
F2G's Olorofim Receives Both FDA Orphan Drug Designation for Coccidioidomycosis (Valley Fever) and FDA QIDP Designation for Multiple Fungal Infections
Olorofim is currently in Phase 2b development for the treatment of life-threatening fungal infections
MANCHESTER, England and VIENNA, Austria, June 10, 2020 -- (Healthcare Sales & Marketing Network) -- F2G Ltd, a UK- and Austria-based biotech developin... Biopharmaceuticals, FDA F2G, orotomides, fungal infection, antifungal, Coccidioidomycosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 10, 2020 Category: Pharmaceuticals Source Type: news
Reprogramming of immune system cures child with often-fatal fungal infection
(University of California - Los Angeles Health Sciences) In the June 11 issue of the New England Journal of Medicine, a team of UCLA physicians and scientists describes the first case of immune modulation being used to cure a severe and often fatal fungal infection. The team 'retuned' a 4-year-old's immune system so that it could fight off disseminated coccidioidomycosis. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 10, 2020 Category: Infectious Diseases Source Type: news
Janssen Announces Submission of Two Applications to U.S. FDA Seeking Approval of SIMPONI ARIA ® (golimumab) for the Treatment of Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis
HORSHAM, PA, April 24, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of two supplemental Biologics License Applications (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval of SIMPONI ARIA® (golimumab) for the treatment of polyarticular juvenile idiopathic arthritis (pJIA) and juvenile psoriatic arthritis (jPsA), in patients two years of age and older in combination with methotrexate. If approved for these indications, SIMPONI ARIA would be the first anti-tumor necrosis factor (TNF)-alpha biologic agent administered by intravenous infusion available...
Source: Johnson and Johnson - April 24, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news
Developing Antifungal Drugs for the Treatment of Coccidioidomycosis (Valley Fever) Infection - 08/05/2020 - 08/05/2020
Developing Antifungal Drugs for the Treatment of Coccidiodomycosis (Valley Fever) Infection (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 16, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Developing Antifungal Drugs for the Treatment of Coccidiodomycosis (Valley Fever) Infection - 08/05/2020 - 08/05/2020
Developing Antifungal Drugs for the Treatment of Coccidiodomycosis (Valley Fever) Infection (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 31, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Developing Antifungal Drugs for the Treatment of Coccidiodomycosis (Valley Fever) Infection - 05/08/2020 - 05/08/2020
Developing Antifungal Drugs for the Treatment of Coccidiodomycosis (Valley Fever) Infection (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 28, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Sudan: Rift Valley Fever Suspected in Sudan's Red Sea State, Mycetoma Plagues El Gezira
[Radio Dabanga] Red Sea State / El Gezira -The deaths of large numbers of livestock and cases of fever among residents in Aryab in Sudan's Red Sea state, have raised concerns for the possible re-emergence of Rift Valley fever in the area. Mycetoma infections are plaguing El Gezira state. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 21, 2020 Category: African Health Source Type: news
